Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Codiak BioSciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −7 vs. Q3 2022
- Shares held
- 14.6M
- −2.62M (−15.2%) vs. Q3 2022
- Total value
- $5.76M
- −$7.66M (−57.1%) vs. Q3 2022
- New holders
- 6
- 10 more added
- Sold out
- 13
- 12 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $0 |
| Q1 2023 | 27 | $1.44M |
| Q4 2022 | 40 | $5.76M |
| Q3 2022 | 48 | $13.6M |
| Q2 2022 | 49 | $33.9M |
| Q1 2022 | 62 | $86.5M |
| Q4 2021 | 51 | $145.4M |
| Q3 2021 | 56 | $223.6M |
| Q2 2021 | 52 | $259.9M |
| Q1 2021 | 47 | $187.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Codiak BioSciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,605,593 | $1.83M | 0.00% | +125,159+2.8% | Added |
| Flagship Pioneering Inc. | 3,540,636 | $1.38M | 0.04% | 00.0% | Unchanged |
| Laurion Capital Management LP | 2,013,300 | $800.5K | 0.02% | 00.0% | Unchanged |
| University of Texas/Texas Am Investment Managment Co | 847,108 | $337.0K | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 823,736 | $327.5K | 0.00% | +3790.0% | Added |
| Alyeska Investment Group, L.P. | 666,891 | $265.2K | 0.00% | −65,702−9.0% | Reduced |
| Millennium Management LLC | 300,811 | $120.0K | 0.00% | −53,160−15.0% | Reduced |
| Renaissance Technologies LLC | 300,852 | $120.0K | 0.00% | +232,552+340.5% | Added |
| Ensign Peak Advisors, Inc | 252,782 | $100.5K | 0.00% | −267,539−51.4% | Reduced |
| Artal Group S.A. | 200,000 | $80.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 187,833 | $74.7K | 0.00% | −125,089−40.0% | Reduced |
| Geode Capital Management, LLC | 161,871 | $64.0K | 0.00% | −379−0.2% | Reduced |
| Forefront Analytics, LLC | 99,935 | $39.7K | 0.02% | +43,450+76.9% | Added |
| Victory Capital Management Inc | 69,102 | $27.5K | 0.00% | −5,336−7.2% | Reduced |
| Parametrica Management Ltd | 65,098 | $25.9K | 0.05% | 00.0% | Unchanged |
| Virtu Financial LLC | 52,402 | $21.0K | 0.00% | +52,402 | New |
| Bank of America Corp | 48,572 | $19.3K | 0.00% | +34,016+233.7% | Added |
| State Street Corp | 48,349 | $19.2K | 0.00% | −7,000−12.6% | Reduced |
| Prudential Financial Inc | 47,800 | $19.0K | 0.00% | +11,200+30.6% | Added |
| Citadel Advisors LLC | 32,948 | $13.1K | 0.00% | +32,948 | New |
| Two Sigma Investments, LP | 29,453 | $11.7K | 0.00% | +29,453 | New |
| Northern Trust Corp | 26,131 | $10.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 25,662 | $10.0K | 0.00% | +19,089+290.4% | Added |
| Acadian Asset Management LLC | 23,915 | $9.00K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 20,328 | $8.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,051 | $6.78K | 0.00% | −16,048−48.5% | Reduced |
| Pathstone Family Office, LLC | 15,000 | $5.96K | 0.00% | +3,000+25.0% | Added |
| Two Sigma Advisers, LP | 13,600 | $5.41K | 0.00% | +13,600 | New |
| National Asset Management, Inc. | 10,000 | $3.98K | 0.00% | −4,172−29.4% | Reduced |
| Belpointe Asset Management LLC | 2,506 | $996 | 0.00% | +2,506 | New |
| Citigroup Inc | 449 | $179 | 0.00% | +22+5.2% | Added |
| US Bancorp | 300 | $119 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 163 | $65 | 0.00% | −285−63.6% | Reduced |
| UBS Group AG | 91 | $36 | 0.00% | −159−63.6% | Reduced |
| Salem Investment Counselors Inc | 50 | $20 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 22 | $9 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 22 | $9 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 79 | $0 | 0.00% | −1,299−94.3% | Reduced |
| Advisor Group Holdings, Inc. | 310 | $0 | 0.00% | +272+715.8% | Added |
| Simplex Trading, LLC | 152 | $0 | 0.00% | +152 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Alaska Permanent Fund Corp | 0 | $0 | 0.00% | −980,194−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −488,157−100.0% | Sold out |
| Trellus Management Company, LLC | 0 | $0 | 0.00% | −64,582−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −38,209−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −38,019−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −18,046−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −15,198−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,421−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −9,100−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −213−100.0% | Sold out |
| Empery Asset Management, LP | – | – | – | – | Not filed |